tiprankstipranks
Advertisement
Advertisement

GB:HVO Stock Latest News

hVIVO wins £6m influenza human challenge trial to test monoclonal antibody
Company AnnouncementshVIVO wins £6m influenza human challenge trial to test monoclonal antibody
8h ago
hVIVO Director Brendan Buckley Sells Shares Ahead of Board Exit
PremiumCompany Announcements
hVIVO Director Brendan Buckley Sells Shares Ahead of Board Exit
13d ago
hVIVO Wins Landmark Phase III Human Challenge Contract for ILiAD’s Whooping Cough Vaccine
PremiumCompany Announcements
hVIVO Wins Landmark Phase III Human Challenge Contract for ILiAD’s Whooping Cough Vaccine
15d ago
hVIVO Publishes 2025 Annual Report and Sets May AGM Date
PremiumCompany Announcements
hVIVO Publishes 2025 Annual Report and Sets May AGM Date
20d ago
Open Orphan Plc Earnings Call: Diversifying Amid Strain
PremiumCompany Announcements
Open Orphan Plc Earnings Call: Diversifying Amid Strain
21d ago
hVIVO Reshapes Clinical Platform as 2025 Profits Slide on Sector Headwinds
PremiumCompany AnnouncementshVIVO Reshapes Clinical Platform as 2025 Profits Slide on Sector Headwinds
22d ago
hVIVO Rebrands as Unified End-to-End Clinical Development Partner
Premium
Company Announcements
hVIVO Rebrands as Unified End-to-End Clinical Development Partner
23d ago
hVIVO seals Traws Pharma deal for Phase 2a influenza human challenge trial
Premium
Company Announcements
hVIVO seals Traws Pharma deal for Phase 2a influenza human challenge trial
23d ago
hVIVO sets 15 April date to unveil 2025 final results
PremiumCompany Announcements
hVIVO sets 15 April date to unveil 2025 final results
1M ago
hVIVO Issues New Shares as Part of Cryostore Acquisition
PremiumCompany Announcements
hVIVO Issues New Shares as Part of Cryostore Acquisition
2M ago
hVIVO upgraded to Buy from Add at Peel Hunt
PremiumThe Fly
hVIVO upgraded to Buy from Add at Peel Hunt
3M ago
hVIVO Beats EBITDA Guidance as Acquisitions Cement Full-Service CRO Platform
PremiumCompany Announcements
hVIVO Beats EBITDA Guidance as Acquisitions Cement Full-Service CRO Platform
3M ago
hVIVO Sets Date for 2025 Trading Update and Investor Presentation
PremiumCompany AnnouncementshVIVO Sets Date for 2025 Trading Update and Investor Presentation
3M ago
hVIVO Bolsters Board with Appointment of Richard Cotton as Non-Executive Director
Premium
Company Announcements
hVIVO Bolsters Board with Appointment of Richard Cotton as Non-Executive Director
5M ago
hVIVO Leadership Increases Stake, Signaling Confidence in Growth
Premium
Company Announcements
hVIVO Leadership Increases Stake, Signaling Confidence in Growth
5M ago
hVIVO’s Client Cidara Acquired by MSD After Successful Trial
PremiumCompany Announcements
hVIVO’s Client Cidara Acquired by MSD After Successful Trial
5M ago
hVIVO’s Role in Cidara’s $9.2 Billion Acquisition by MSD
PremiumCompany Announcements
hVIVO’s Role in Cidara’s $9.2 Billion Acquisition by MSD
5M ago
hVIVO’s German Subsidiary Secures £5 Million in New Contracts
PremiumCompany Announcements
hVIVO’s German Subsidiary Secures £5 Million in New Contracts
6M ago
hVIVO Unveils Positive Data from Novel Human Challenge Models at Key Conferences
PremiumCompany Announcements
hVIVO Unveils Positive Data from Novel Human Challenge Models at Key Conferences
6M ago
hVIVO to Present at Europe’s Largest Healthcare Conference
PremiumCompany AnnouncementshVIVO to Present at Europe’s Largest Healthcare Conference
6M ago
hVIVO Reports Interim Results and Eyes Growth in 2026
Premium
Company Announcements
hVIVO Reports Interim Results and Eyes Growth in 2026
8M ago
hVIVO to Release Interim Results and Host Investor Presentation
Premium
Company Announcements
hVIVO to Release Interim Results and Host Investor Presentation
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >